Cargando…

Epidemiological Study of Autism Spectrum Disorders in Greece for 2021: Nationwide Prevalence in 2–17-Year-Old Children and Regional Disparities

This study estimated the crude prevalence of autism spectrum disorders (ASD) in Greece in 2021. A retrospective study was conducted for 2021 using data provided for research purposes for the first time by the Greek National Health Service Organization for Healthcare Services Provision (EOPYY) relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouznetsov, Raissa, Angelopoulos, Panagiotis, Moulinos, Spyridon, Dimakos, Ioannis, Gourzis, Philippos, Jelastopulu, Eleni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095433/
https://www.ncbi.nlm.nih.gov/pubmed/37048594
http://dx.doi.org/10.3390/jcm12072510
_version_ 1785024082365906944
author Kouznetsov, Raissa
Angelopoulos, Panagiotis
Moulinos, Spyridon
Dimakos, Ioannis
Gourzis, Philippos
Jelastopulu, Eleni
author_facet Kouznetsov, Raissa
Angelopoulos, Panagiotis
Moulinos, Spyridon
Dimakos, Ioannis
Gourzis, Philippos
Jelastopulu, Eleni
author_sort Kouznetsov, Raissa
collection PubMed
description This study estimated the crude prevalence of autism spectrum disorders (ASD) in Greece in 2021. A retrospective study was conducted for 2021 using data provided for research purposes for the first time by the Greek National Health Service Organization for Healthcare Services Provision (EOPYY) related to the ICD-10 diagnosis codes F84.0–F84.9 (ASD). Treatments were categorized by gender, age, and location. Statistical analysis was performed using the open-source software R. In total, 15,706 children aged 2–17 years were registered with ASD: 12,380 boys and 3326 girls. In total, 6,117,910 therapies were prescribed: 4,844,173 for boys and 1,273,737 for girls. Boys are estimated to be diagnosed 3.5 times more often than girls. On average, approximately 390 treatments are prescribed per person per year for both sexes. The annual prevalence is estimated at 0.94%, ranging from 0.42% to 1.44% depending on geographic region. Our findings provide evidence-based data for the planning of policies regarding health, education, and employment for people with ASD. The number of children and treatments makes ASD a public health concern to support children and their families and ensure equal participation in all aspects of society.
format Online
Article
Text
id pubmed-10095433
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100954332023-04-13 Epidemiological Study of Autism Spectrum Disorders in Greece for 2021: Nationwide Prevalence in 2–17-Year-Old Children and Regional Disparities Kouznetsov, Raissa Angelopoulos, Panagiotis Moulinos, Spyridon Dimakos, Ioannis Gourzis, Philippos Jelastopulu, Eleni J Clin Med Article This study estimated the crude prevalence of autism spectrum disorders (ASD) in Greece in 2021. A retrospective study was conducted for 2021 using data provided for research purposes for the first time by the Greek National Health Service Organization for Healthcare Services Provision (EOPYY) related to the ICD-10 diagnosis codes F84.0–F84.9 (ASD). Treatments were categorized by gender, age, and location. Statistical analysis was performed using the open-source software R. In total, 15,706 children aged 2–17 years were registered with ASD: 12,380 boys and 3326 girls. In total, 6,117,910 therapies were prescribed: 4,844,173 for boys and 1,273,737 for girls. Boys are estimated to be diagnosed 3.5 times more often than girls. On average, approximately 390 treatments are prescribed per person per year for both sexes. The annual prevalence is estimated at 0.94%, ranging from 0.42% to 1.44% depending on geographic region. Our findings provide evidence-based data for the planning of policies regarding health, education, and employment for people with ASD. The number of children and treatments makes ASD a public health concern to support children and their families and ensure equal participation in all aspects of society. MDPI 2023-03-27 /pmc/articles/PMC10095433/ /pubmed/37048594 http://dx.doi.org/10.3390/jcm12072510 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kouznetsov, Raissa
Angelopoulos, Panagiotis
Moulinos, Spyridon
Dimakos, Ioannis
Gourzis, Philippos
Jelastopulu, Eleni
Epidemiological Study of Autism Spectrum Disorders in Greece for 2021: Nationwide Prevalence in 2–17-Year-Old Children and Regional Disparities
title Epidemiological Study of Autism Spectrum Disorders in Greece for 2021: Nationwide Prevalence in 2–17-Year-Old Children and Regional Disparities
title_full Epidemiological Study of Autism Spectrum Disorders in Greece for 2021: Nationwide Prevalence in 2–17-Year-Old Children and Regional Disparities
title_fullStr Epidemiological Study of Autism Spectrum Disorders in Greece for 2021: Nationwide Prevalence in 2–17-Year-Old Children and Regional Disparities
title_full_unstemmed Epidemiological Study of Autism Spectrum Disorders in Greece for 2021: Nationwide Prevalence in 2–17-Year-Old Children and Regional Disparities
title_short Epidemiological Study of Autism Spectrum Disorders in Greece for 2021: Nationwide Prevalence in 2–17-Year-Old Children and Regional Disparities
title_sort epidemiological study of autism spectrum disorders in greece for 2021: nationwide prevalence in 2–17-year-old children and regional disparities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095433/
https://www.ncbi.nlm.nih.gov/pubmed/37048594
http://dx.doi.org/10.3390/jcm12072510
work_keys_str_mv AT kouznetsovraissa epidemiologicalstudyofautismspectrumdisordersingreecefor2021nationwideprevalencein217yearoldchildrenandregionaldisparities
AT angelopoulospanagiotis epidemiologicalstudyofautismspectrumdisordersingreecefor2021nationwideprevalencein217yearoldchildrenandregionaldisparities
AT moulinosspyridon epidemiologicalstudyofautismspectrumdisordersingreecefor2021nationwideprevalencein217yearoldchildrenandregionaldisparities
AT dimakosioannis epidemiologicalstudyofautismspectrumdisordersingreecefor2021nationwideprevalencein217yearoldchildrenandregionaldisparities
AT gourzisphilippos epidemiologicalstudyofautismspectrumdisordersingreecefor2021nationwideprevalencein217yearoldchildrenandregionaldisparities
AT jelastopulueleni epidemiologicalstudyofautismspectrumdisordersingreecefor2021nationwideprevalencein217yearoldchildrenandregionaldisparities